Related Experiment Videos
Late preventive effects of several anticalmodulin drugs on galactosamine-induced liver necrosis
Research Communications in Chemical Pathology and Pharmacology
|February 1, 1985
Abstract:
Four anticalmodulin drugs: trifluoperazine (TFP), pimozide (PMZ), thioridazine (TDZ) and imipramine (IMP) (50 mg/kg, ip) were able to partially prevent Galactosamine (GAL) (600 mg/kg, ip) induced liver necrosis when given 6 h after the hepatotoxin. IMP was also effective 10 h after GAL. The possibility of calmodulin participation in late stages of GAL-induced liver injury is analyzed.
Insights
Anticalmodulin drugs like imipramine partially prevented Galactosamine-induced liver necrosis when administered hours after the toxin. This suggests calmodulin may play a role in the later stages of liver injury.
Area of Science:
- Pharmacology
- Hepatology
- Biochemistry
Background:
- Galactosamine (GAL) is a hepatotoxin that induces liver necrosis.
- Calmodulin is a calcium-binding protein involved in various cellular processes.
Purpose of the Study:
- To investigate the potential of anticalmodulin drugs to prevent Galactosamine-induced liver injury.
- To explore the role of calmodulin in the late stages of Galactosamine-induced liver damage.
Main Methods:
- Four anticalmodulin drugs (trifluoperazine, pimozide, thioridazine, imipramine) were administered at specific time points after Galactosamine injection.
- Liver necrosis was assessed to evaluate the protective effects of the drugs.
Main Results:
- Trifluoperazine, pimozide, thioridazine, and imipramine (50 mg/kg) partially prevented Galactosamine-induced liver necrosis when given 6 hours post-toxin.
- Imipramine demonstrated efficacy even when administered 10 hours after Galactosamine.
Conclusions:
- Anticalmodulin drugs show potential in mitigating Galactosamine-induced liver injury.
- The findings suggest a possible involvement of calmodulin in the progression of Galactosamine-induced liver damage.